Question: The UK Expert Scientific Group on Phase 1 Trials in their Final Report of TGN1412 makes 22 recommendations. Please comment on the recommendations in general or a few in particular. Are they reasonable, appropriate, and will they improve the overall conduct of phase 1 studies? Do you have strong disagreement with any of them?